Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ALS drug trial launches: hope for slowing the disease?

NCT ID NCT07287397

Recruiting now Disease control Sponsor: Vector Y Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called VTx-002 in 12 people with ALS. The main goal is to check if the drug is safe and tolerable when given as a single injection into the fluid around the brain and spinal cord. Researchers will also look for signs that the drug might slow down the disease, but this is not a cure and participants will still need ongoing care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYOTROPHIC LATERAL SCLEROSIS

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Herbert Irving Comprehensive Cancer Center

    NOT_YET_RECRUITING

    New York, New York, 10032, United States

  • Kings College Hospital

    NOT_YET_RECRUITING

    London, SE5 9RS, United Kingdom

  • Mayo Clinic in Florida

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Royal Hallamshire Hospital

    NOT_YET_RECRUITING

    Sheffield, S10 2JF, United Kingdom

  • Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • St Joseph's Hospital and medical Center - Barrow Neurological Institute

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85013, United States

  • UMC Utrecht

    RECRUITING

    Utrecht, Netherlands

  • UZ Leuven

    NOT_YET_RECRUITING

    Leuven, Belgium

  • University of California San Diego Medical Center

    RECRUITING

    San Diego, California, 92121, United States

  • University of Miami School of Science

    NOT_YET_RECRUITING

    Miami, Florida, 33136, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.